RAP 0.00% 20.5¢ resapp health limited

Ann: Study shows efficacy of ResAppDx use with masks, page-13

  1. 46 Posts.
    lightbulb Created with Sketch. 97
    The significance of this announcement from a commercialisation perspective cannot be understated.

    Massive tick from a practical standpoint! I don't understand how the company believed this was not market sensitive.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.